Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings

Obstetrics and Gynecology

Volumn 93, Issue 1, 1999, Pages 21-24

  Rubin, Stephen C ^a   Randall, Thomas C ^b   Armstrong, Katrina A ^b   Chi, Dennis S ^b   Hoskins, William J ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; HUMAN; LAPAROTOMY; MIDDLE AGED; MORTALITY; OVARY TUMOR; PROGNOSIS; REMISSION; REOPERATION; STATISTICAL MODEL; SURVIVAL RATE; TIME; TUMOR RECURRENCE;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LAPAROTOMY; LOGISTIC MODELS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PROGNOSIS; REMISSION INDUCTION; REOPERATION; SURVIVAL RATE; TIME FACTORS;

EID: 0032614543     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00334-2     Document Type: Article

References (12)

1. Rubin SC, Lewis JJ. Second-look surgery in ovarian carcinoma. Crit Rev Oncol Hematol 1988;8:75-91.
2. Barter J, Barnes W. Second-look laparotomy. In: Rubin S, Sutton G eds. Ovarian cancer. New York: McGraw-Hill, 1993:269-300.
3. Omura G, Blessing JA, Ehrlich CE, Miller A, Yordan E, Creasman WT, et al. A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group study. Cancer 1986;57:1725-30.
4. McGuire W, Hoskins W, Brady M, Kucera P, Partridge E, Look K, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1-6.
5. Rubin SC, Hoskins WJ, Hakes TB, Markman M, Cain JM, Lewis JJ. Recurrence after negative second-look laparotomy for ovarian cancer: Analysis of risk factors. Am J Obstet Gynecol 1988;159: 1094-8.
6. Rubin SC, Hoskins WJ, Saigo PE, Chapman D, Hakes TB, Markman M, et al. Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy. Gynecol Oncol 1991;42:137-41.
7. Cain JM, Saigo PE, Pierce VK, Clark DG, Jones WB, Smith DH, et al. A review of second-look laparotomy for ovarian cancer. Gynecol Oncol 1986;23:14-25.
8. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
9. Cox D. Regression models and life tables. J R Stat Soc B 1972;34: 187-202.
10. Rubin SC, Jones WB, Curtin JP, Barakat RR, Hakes TB, Hoskins WJ. Second-look laparotomy in stage I ovarian cancer following comprehensive surgical staging. Obstet Gynecol 1993;82:139-42.
11. Chiara S, Lionetto R, Campora E, Oliva C, Merlini L, Bruzzi P, et al. Long-term prognosis following macroscopic complete response at second-look laparotomy in advanced ovarian cancer patients treated with platinum-based chemotherapy. The Gruppo Oncologico Nord Ovest. Eur J Cancer 1995;31A:296-301.
12. Bolis G, Villa A, Guarnerio P, Ferraris C, Gavoni N, Giardina G, et al. Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy. Cancer 1996;77: 128-31.